Impact of a Clinical Pathway for Hospital Management of Community-Acquired Pneumonia: A Retrospective Cohort Study
- 1 June 2021
- journal article
- Published by SciRes Literature LLC in Journal of Biomedical Research & Environmental Sciences
- p. 450-459
- https://doi.org/10.37871/jbres1259
Abstract
Introduction: Community-acquired pneumonia is a prevalent disease that is managed in heterogeneous ways. Clinical pathways have been proposed as one way to mitigate this variability, but few implementation experiences have been published. The primary objective of this study is to analyse the effects of implementing a standardised clinical pathway for community-acquired pneumonia on length of hospital stay. Methods: Retrospective cohort study comparing two equivalent time periods with and without a clinical pathway. We described patient characteristics in both periods and compared mean length of hospital stay, mortality, rate of complications, and readmissions within 30 days. Results: A total of 170 patients were included across both periods. Mean length of hospital stay in patients treated before implementation of the clinical pathway was 6.05 days versus 5.43 days afterward (p = 0.28). The segmented regression analysis showed a change in slope for the length of hospital stay (0.04) following implementation of the clinical pathway. The proportion of patients hospitalised for more than 6 days was 37.5% in the first period, compared to 29.6% in the second (p = 0.088). Multivariable analysis showed that nonadherence to the clinical pathway was associated with a hospital stay of longer than 6 days (p = 0.048). Mortality dropped from 10.5% to 4.7% after the clinical pathway was established (p = 0.12). The proportion of patients readmitted within 30 days due to CAP was 8.8% before the establishment of the clinical pathway and 0% afterwards (p = 0.006). Conclusion: A clinical pathway for managing community-acquired pneumonia was associated with a reduction in length of hospital stay and readmittance. There was a trend towards mortality reduction.Keywords
This publication has 31 references indexed in Scilit:
- A clinical pathway for community-acquired pneumonia: an observational cohort studyBMC Infectious Diseases, 2011
- Clinical and economic burden of community-acquired pneumonia among adults in EuropeThorax, 2010
- Global and Local Epidemiology of Community-Acquired Pneumonia: The Experience of the CAPNETZ NetworkSeminars in Respiratory and Critical Care Medicine, 2009
- Epidemiology of community-acquired pneumonia in older adults: A population-based studyRespiratory Medicine, 2009
- The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 StudyBMC Public Health, 2008
- Demographics, guidelines, and clinical experience in severe community-acquired pneumoniaCritical Care, 2008
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- A population-based study of the costs of care for community-acquired pneumoniaEuropean Respiratory Journal, 2004
- Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax, 2003
- The burden of community-acquired pneumonia in SpainEuropean Journal of Public Health, 2001